Wells Fargo Sticks to Their Buy Rating for Metlife

By Jason Carr

Wells Fargo analyst Sean Dargan reiterated a Buy rating on Metlife (NYSE: MET) yesterday. The company’s shares closed yesterday at $54.54.

According to TipRanks.com, Dargan is a 3-star analyst with an average return of 7.2% and a 60.6% success rate. Dargan covers the Financial sector, focusing on stocks such as Marsh & Mclennan Companies, Prudential Financial Inc, and Fidelity & Guaranty Life.

Metlife has an analyst consensus of Strong Buy, with a price target consensus of $59.80.

Based on Metlife’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $16.66 billion and quarterly net profit of $826 million. In comparison, last year the company earned revenue of $17.24 billion and had a net profit of $2.2 billion.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MetLife, Inc. provides insurance and financial services to individual and institutional customers. It offers life insurance, annuities, automobile and homeowner’s insurance and retail banking services to individuals as well as group insurance, reinsurance and retirement and savings products and services.